Gemphire Therapeutics Inc.(Nasdaq: GEMP) priced its public offering of more than 3.1 million common shares at the discounted price of $7.00 per share sending the stock price plummeting $2.59 to close at $6.24.
Gemphire Therapeutics prices offering at discount
February 08, 2018 at 16:43 PM EST
